{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T22:48:26Z","timestamp":1725835706534},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11096-013-9751-6","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T11:03:57Z","timestamp":1358766237000},"page":"306-308","source":"Crossref","is-referenced-by-count":10,"title":["Vocal cord paralysis during the treatment of mantle cell lymphoma with vincristine"],"prefix":"10.1007","volume":"35","author":[{"given":"Serkan Feyyaz","family":"Yalin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Trabulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Serap","family":"Yalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsah Yenidunya","family":"Yalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seniz","family":"Ongoren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Riza","family":"Altiparmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"9751_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mus.880100115","volume":"10","author":"Z Sahenk","year":"1987","unstructured":"Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve. 1987;10:80\u20134.","journal-title":"Muscle Nerve"},{"issue":"3","key":"9751_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.410010311","volume":"1","author":"LS Green","year":"1977","unstructured":"Green LS, Donoso JA, Heller-Bettinger IE, Samson FE. Axonal transport disturbances in vincristine-induced peripheral neuropathy. Ann Neurol. 1977;1(3):255\u201362.","journal-title":"Ann Neurol"},{"key":"9751_CR3","first-page":"155","volume":"79","author":"SG Oakes","year":"1987","unstructured":"Oakes SG, Santone KS, Powis G. Effect of some anticancer drugs on the surface membrane electrical properties of differentiated murine neuroblastoma cells. J Natl Cancer Inst. 1987;79:155\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"9751_CR4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","volume":"25","author":"AR Chauvenet","year":"2003","unstructured":"Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric oncology group study. J Pediatr Hematol Oncol. 2003;25(4):316\u201320.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"9751_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-510X(70)90013-4","volume":"10","author":"WG Bradley","year":"1970","unstructured":"Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man: clinical, electrophysiological, and pathological studies. J Neurol Sci. 1970;10(2):107\u201331.","journal-title":"J Neurol Sci"},{"issue":"1","key":"9751_CR6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mus.880100115","volume":"10","author":"Z Sahenk","year":"1987","unstructured":"Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine induced neuropathy. Muscle Nerve. 1987;10(1):80\u20134.","journal-title":"Muscle Nerve"},{"issue":"2","key":"9751_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0305-7372(94)90027-2","volume":"20","author":"MK Tuxen","year":"1994","unstructured":"Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994;20(2):191\u2013214.","journal-title":"Cancer Treat Rev"},{"key":"9751_CR8","first-page":"613","volume":"23","author":"RA Bohannon","year":"1963","unstructured":"Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemia. Cancer Res. 1963;23:613\u201321.","journal-title":"Cancer Res"},{"key":"9751_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02759902","volume":"73","author":"A Bay","year":"2006","unstructured":"Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr. 2006;73:531\u20133.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"9751_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"9751_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archoto.2008.514","volume":"135","author":"G Kuruvilla","year":"2009","unstructured":"Kuruvilla G, Perry S, Wilson B, El-Hakim H. The natural history of vincristine-induced laryngeal paralysis in children. Arch Otolaryngol Head Neck Surg. 2009;135(1):101\u20135.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"9751_CR12","first-page":"68","volume":"46","author":"R Naithani","year":"2009","unstructured":"Naithani R, Dolai TK, Kumar R. Bilateral vocal cord paralysis following treatment with vincristine. Indian Pediatr. 2009;46(1):68\u20139.","journal-title":"Indian Pediatr"},{"issue":"5","key":"9751_CR13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPH.0b013e3181e01584","volume":"32","author":"ZA Latiff","year":"2010","unstructured":"Latiff ZA, Kamal NA, Jahendran J, Alias H, Goh BS, Syed Zakaria SZ, et al. Vincristine-induced vocal cord palsy: case report and review of the literature. J Pediatr Hematol Oncol. 2010;32(5):407\u201310.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"9751_CR14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1752-1947-6-128","volume":"6","author":"P Farruggia","year":"2012","unstructured":"Farruggia P, Tropia S, Cannella S, Bruno G, Oddo G, D\u2019Angelo P. Vocal cord palsy after vincristine treatment in a child and the inefficacy of glutamic acid in the prevention of relapse: a case report. J Med Case Rep. 2012;6(1):128.","journal-title":"J Med Case Rep"},{"key":"9751_CR15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bmj.1.6071.1251","volume":"1","author":"JA Whittaker","year":"1977","unstructured":"Whittaker JA, Griffith IP. Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. Br Med J. 1977;1:1251\u20132.","journal-title":"Br Med J"},{"issue":"1","key":"9751_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2257.1998.00102.x","volume":"20","author":"K Rezvani","year":"1998","unstructured":"Rezvani K, Bain BJ, Coulter CA. Loss of singing ability caused by vincristine. Clin Lab Haematol. 1998;20(1):47\u20138.","journal-title":"Clin Lab Haematol"},{"key":"9751_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1460-9592.2002.00816.x","volume":"12","author":"DL Anghelescu","year":"2002","unstructured":"Anghelescu DL, De Armendi AJ, Thompson JW, Sillos EM, Pui CH, Sandlund JT. Vincristine induced vocal cord paralysis in an infant. Paediatr Anaesth. 2002;12:168\u201370.","journal-title":"Paediatr Anaesth"},{"key":"9751_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/088800101300002973","volume":"18","author":"MR Jeng","year":"2001","unstructured":"Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137\u201342.","journal-title":"Pediatr Hematol Oncol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9751-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9751-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9751-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:25:46Z","timestamp":1562599546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9751-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9751"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9751-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}